IE44824B1 - Process for the isolation of a placenta-specific glycoprotein - Google Patents

Process for the isolation of a placenta-specific glycoprotein

Info

Publication number
IE44824B1
IE44824B1 IE787/77A IE78777A IE44824B1 IE 44824 B1 IE44824 B1 IE 44824B1 IE 787/77 A IE787/77 A IE 787/77A IE 78777 A IE78777 A IE 78777A IE 44824 B1 IE44824 B1 IE 44824B1
Authority
IE
Ireland
Prior art keywords
ppg
related proteins
carrier
solution
antigenically related
Prior art date
Application number
IE787/77A
Other languages
English (en)
Other versions
IE44824L (en
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of IE44824L publication Critical patent/IE44824L/xx
Publication of IE44824B1 publication Critical patent/IE44824B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IE787/77A 1976-04-17 1977-04-15 Process for the isolation of a placenta-specific glycoprotein IE44824B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2616984A DE2616984C3 (de) 1976-04-17 1976-04-17 Verfahren zur Isolierung und Reinigung eines plazentenspezifischen Glycoproteins

Publications (2)

Publication Number Publication Date
IE44824L IE44824L (en) 1977-10-17
IE44824B1 true IE44824B1 (en) 1982-04-07

Family

ID=5975638

Family Applications (1)

Application Number Title Priority Date Filing Date
IE787/77A IE44824B1 (en) 1976-04-17 1977-04-15 Process for the isolation of a placenta-specific glycoprotein

Country Status (20)

Country Link
JP (1) JPS52154509A (sv)
AT (1) AT362057B (sv)
AU (1) AU517434B2 (sv)
BE (1) BE853711A (sv)
CA (1) CA1101847A (sv)
CH (2) CH630643A5 (sv)
DE (1) DE2616984C3 (sv)
DK (1) DK168577A (sv)
ES (2) ES457714A1 (sv)
FI (1) FI60875C (sv)
FR (1) FR2348222A1 (sv)
GB (1) GB1555197A (sv)
IE (1) IE44824B1 (sv)
IL (1) IL51883A (sv)
IT (1) IT1075832B (sv)
LU (1) LU77143A1 (sv)
NL (1) NL7703963A (sv)
NO (1) NO146747C (sv)
NZ (1) NZ183878A (sv)
SE (1) SE7704359L (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2640387C3 (de) * 1976-09-08 1981-01-22 Behringwerke Ag, 3550 Marburg Gewebespezifisches Protein und Verfahren zu dessen Herstellung
DE2720704C2 (de) * 1977-05-07 1986-09-25 Behringwerke Ag, 3550 Marburg Neues Glycoprotein, Verfahren zu seiner Herstellung und seine Verwendung
DE2745680A1 (de) * 1977-10-11 1979-04-12 Behringwerke Ag Kontrazeptives mittel
EP0029893B1 (de) * 1979-11-02 1987-05-20 Karl Prof. Dr. Theurer Verfahren zur Anreicherung tumorhemmender Wirkfaktoren
DE3013724A1 (de) 1980-04-10 1981-10-15 Behringwerke Ag, 3550 Marburg Neues protein pp (pfeil abwaerts)9(pfeil abwaerts), verfahren zu seiner anreicherung und gewinnung sowieseine verwendung
DE3334405A1 (de) * 1983-09-23 1985-04-04 Behringwerke Ag, 3550 Marburg Membranassoziierte proteine (mp(pfeil abwaerts)2(pfeil abwaerts)), verfahren zu ihrer gewinnung sowie ihre verwendung
NZ212523A (en) * 1985-06-24 1989-01-06 Univ Massey Mobile phase for purification of proteins by high performance liquid chromatography
US20030220233A1 (en) 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US5968477A (en) 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
CA2190727C (en) * 1994-05-19 2006-07-18 Sudhakar Kasina Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
US6005083A (en) * 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms

Also Published As

Publication number Publication date
NZ183878A (en) 1980-04-28
DE2616984B2 (de) 1981-01-29
ES457714A1 (es) 1978-02-16
NO146747B (no) 1982-08-23
IL51883A (en) 1980-02-29
NO771316L (no) 1977-10-18
AT362057B (de) 1981-04-27
FI60875C (fi) 1982-04-13
DE2616984C3 (de) 1981-10-29
FR2348222B1 (sv) 1980-02-08
IE44824L (en) 1977-10-17
CH630643A5 (en) 1982-06-30
ATA266377A (de) 1980-09-15
JPS52154509A (en) 1977-12-22
SE7704359L (sv) 1977-10-18
DE2616984A1 (de) 1977-10-20
FI60875B (fi) 1981-12-31
IL51883A0 (en) 1977-06-30
AU517434B2 (en) 1981-07-30
NL7703963A (nl) 1977-10-19
FR2348222A1 (fr) 1977-11-10
IT1075832B (it) 1985-04-22
FI771186A (sv) 1977-10-18
ES462699A1 (es) 1978-07-01
CH632091A5 (en) 1982-09-15
CA1101847A (en) 1981-05-26
NO146747C (no) 1982-12-01
BE853711A (fr) 1977-10-18
LU77143A1 (sv) 1977-11-14
DK168577A (da) 1977-10-18
AU2431977A (en) 1978-10-19
GB1555197A (en) 1979-11-07

Similar Documents

Publication Publication Date Title
US4217339A (en) Glycoprotein and process for isolating it
CA1242393A (en) Digitalis antibodies, process for the preparation thereof and the use thereof for the therapy of digitalis intoxications
US4191533A (en) Pregnancy-specific β1 -glycoprotein and process for isolating it
US4269825A (en) New glycoprotein and process for isolating it
US4402872A (en) Protein and process for isolating it
IE44824B1 (en) Process for the isolation of a placenta-specific glycoprotein
US4468345A (en) Protein (PP17), a process for concentrating and isolating it and its use
US4302385A (en) Placenta-specific tissue protein PP10
US4746731A (en) Isolated tissue protein PP18
US4500451A (en) New protein PP13 extracted from human placental tissues and use thereof
US4368148A (en) Protein PP9, process for its enrichment and its isolation and its use
US4592863A (en) Protein PP20, a process for obtaining it, and its use
US4065445A (en) Pregnancy-specific β1 -glycoprotein and process for isolating it
US4325866A (en) Protein, PP11, a process for its preparation and its use
US4018885A (en) Steroid-binding globulin and process for preparing it and antibodies thereto
JPS6034916A (ja) 第１ｘ因子および他のビタミンｋ依存性タンパク質の高純度精製
US4309339A (en) Leucine-rich 3,1-S-α2 -glycoprotein, process for isolating it and its use
US4594328A (en) Tissue protein PP21, a process for obtaining it and its use
US4599318A (en) Tissue protein PP19, a process for obtaining it, and its use
Griffiths et al. Purification of human alpha-1-fetoprotein by ammonium sulphate gradient solubilization: development of reagents for radioimmunoassay
CA1065305A (en) PROCESS FOR THE ENRICHMENT OF THE PREGNANCY-SPECIFIC .beta.1-GLYCOPROTEIN
Miani et al. A BRAIN‐SPECIFIC PROTEIN WITH AFFINITY FOR DNA 1
US4859766A (en) Purified appetite-regulating substances of biological orgin, their antibodies, immunocomplexes of the appetite--regulating substances formed with the antibodies and processes for preparing same
Bohn et al. Isolated tissue protein PP 18
Bohn et al. Protein, PP 11, a process for its preparation and its use